NACDS is all in on new strategy
The change means ‘moving faster, investing differently, supporting members more directly and building new capabilities.’
Jeffrey Woldt
Two titans are speeding change
Both retail titans are moving with alacrity to reinvent their core business, even as they invest billions of dollars in other relevant fields — most notably artificial intelligence.
PBM reform: The end of the beginning
The recent release of an interim report by the Federal Trade Commission about what the agency characterizes as “prescription drug middlemen” represents a vindication of sorts for pharmacy advocates who have long contended that PBMs employ business practices that skew the market to their advantage.